SOPHiA GENETICS SA (SOPH) Tops Q1 EPS by 4c ; Offers Guidance

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $15.7 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2024 revenue of $78-81 million, versus the consensus of $79.17 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits